XTL BIOPHARMACEUTICALS LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-11-15: Form 6-K; Period of report 2023-11-15; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea188494-6k_xtlbiopharma.htm.
- 2023-10-20: Form 6-K; Period of report 2023-10-20; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea187052-6k_xtlbiopharma.htm.
- 2023-08-10: Form 6-K; Period of report 2023-08-10; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea182824-6k_xtlbiopharma.htm.
- 2023-05-16: Form 6-K; Period of report 2023-05-16; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea178577-6k_xtlbiopharma.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2023-11-15 | 6-K | 2023-11-15 | REPORT OF FOREIGN PRIVATE ISSUER | ea188494-6k_xtlbiopharma.htm |
| 2023-10-20 | 6-K | 2023-10-20 | REPORT OF FOREIGN PRIVATE ISSUER | ea187052-6k_xtlbiopharma.htm |
| 2023-08-10 | 6-K | 2023-08-10 | REPORT OF FOREIGN PRIVATE ISSUER | ea182824-6k_xtlbiopharma.htm |
| 2023-05-16 | 6-K | 2023-05-16 | REPORT OF FOREIGN PRIVATE ISSUER | ea178577-6k_xtlbiopharma.htm |
| 2023-03-02 | 6-K | 2023-03-02 | FORM 6-K | ea174584-6k_xtlbiophar.htm |
| 2023-02-23 | 6-K | 2023-02-23 | FORM 6-K | ea174164-6k_xtlbio.htm |
| 2023-02-01 | 6-K/A | 2023-02-01 | AMENDMENT 1 TO FORM 6-K | ea172490-6ka_xtlbio.htm |
| 2023-01-20 | 6-K | 2023-01-20 | REPORT OF FOREIGN PRIVATE ISSUER | ea171919-6k_xtlbiopharma.htm |